HOME Research Insight Product Launches and Enhancements, Partnerships, and Collaborations were the Most Widely Adopted Growth Strategies by the Players in the Flow Cytometry Market



Product Launches and Enhancements, Partnerships, and Collaborations were the Most Widely Adopted Growth Strategies by the Players in the Flow Cytometry Market


The global flow cytometry market is expected to reach USD 4.79 Billion by 2022 from USD 3.29 Billion in 2017 growing at a CAGR of 7.8% during forecast period. Factors such as continuous technological advancements in the field of flow cytometry, prevalence of target diseases (such as HIV/AIDS and cancer), growing adoption of flow cytometry in advanced research activities and clinical trials, and the increasing availability of novel application-specific flow cytometry products are driving the growth of the flow cytometry market.

Strategic analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, acquisitions, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the flow cytometry market. Among these business strategies, product launches and enhancements, partnerships, and collaborations were the most widely adopted growth strategies by the players in this market.

Becton, Dickinson and Company (US) held the leading position in the global flow cytometry market in 2016. The company offers a comprehensive range of solutions for flow cytometry-based cell analysis and cell sorting. BD has a broad and balanced geographic footprint through offices located in more than 50 countries, which maximizes marketing opportunities for its products. The company adopts both organic (product development and launches) and inorganic growth strategies (such as collaborations, partnerships, and acquisitions) which help it strengthen its position and increase its revenue base in the flow cytometry market. For instance, in last three years, the company launched several flow cytometry products, such as BD Precise whole transcriptome analysis (WTA) reagents, BD FACSPresto CD4/Hb Cartridge, BD FACSLyric, BD FACSVia, BD FACSMelody, BD FACSymphony, BD FACSCelesta, and BD FACSPresto flow cytometer systems. In addition, BD also entered into various collaborations & partnerships to enhance its R&D capabilities.

Beckman Coulter (US) is another major player in the flow cytometry market in 2016. The company is focused on strengthening its market position in the global flow cytometry market mainly by adopting the strategies such as product launches, agreements, collaboration, and acquisitions. For instance in the past few years, the company acquired Xitogen Technologies, Inc. (China) to strengthen its product R&D and manufacturing activities; entered into a distribution agreement with IncellDx, Inc. (US); and collaborated with Genera Biosystems Limited (Australia). The company also launched a few innovative products in the past three years, such as ClearLLab LS lymphoid screen reagents, CytoFLEX Flow cytometer, and Aquios CL clinical flow cytometer.

Related Reports:

Flow Cytometry Market by Technology (Cell & Bead-based), Product & Services (Analyzer, Sorter, Reagents), Application (Research (Cell Analysis), Clinical (Cancer, HIV)), End User (Academia, Research Institute, Hospital) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports